Stockreport

Vaccinex Reports Fourth Quarter 2020 Financial Results and Provides Corporate Update

Vaccinex, Inc.  (VCNX) 
PDF Reported top-line results from Phase 2 SIGNAL study that indicates potential cognitive benefit of pepinemab in neurodegenerative disease. New Alzheimer’s study expected [Read more]